Capricor Investors Facing Securities Lawsuit Deadline
Investors who experienced financial losses in Capricor Therapeutics securities between December 17, 2025, and July 26, 2026, must act by September 28, 2026, regarding a class action lawsuit.
Faruqi & Faruqi, LLP, a law firm specializing in securities litigation, has issued a reminder to investors concerning a class action lawsuit against Capricor Therapeutics. The deadline for investors to join or take action related to the lawsuit is set for September 28, 2026.
The lawsuit pertains to individuals who purchased or acquired securities in Capricor Therapeutics within a specific period, from December 17, 2025, to July 26, 2026. This timeframe suggests the legal action may be related to events or disclosures made by the company during this interval.
Investors who believe they have suffered losses due to their investment in Capricor during the specified period are encouraged to contact James (Josh) Wilson, a Securities Litigation Partner at Faruqi & Faruqi, LLP. The firm is advising potential claimants on their options moving forward.
This notice highlights the ongoing legal scrutiny that publicly traded companies can face. Further details regarding the specific allegations and the scope of the class action are expected to be made available through legal channels as the September 28, 2026, deadline approaches.